BOLT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bolt Biotherapeutics Inc (BOLT) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock shows no significant trading signals, lacks recent positive news or catalysts, and the financial performance is weak with declining net income and EPS. While the technical indicators are neutral, there is no compelling reason to invest immediately given the lack of growth and momentum.
The MACD is positive but contracting, RSI is neutral at 52.905, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 4.413, with resistance at 4.783 and support at 4.043.
NULL. No recent news or significant trading trends from hedge funds or insiders.
Declining financial performance with a significant drop in net income (-58.39% YoY) and EPS (-53.85% YoY). No recent news or events to drive positive sentiment.
In Q4 2025, revenue remained flat at $2,500,000 YoY. Net income dropped significantly to -$6,631,000 (-58.39% YoY), and EPS fell to -3.84 (-53.85% YoY). Gross margin remained unchanged at 100%.
No data on analyst ratings or price target changes available.
